Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 09/28/09 | Statement of changes in beneficial ownership of securities |
|
2 | ||
| 09/28/09 | Initial statement of beneficial ownership of securities |
|
4 | ||
| 09/28/09 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 09/28/09 | Initial statement of beneficial ownership of securities |
|
1 | ||
| 09/17/09 | SEC-generated letter |
|
3 | ||
| 08/27/09 | Prospectus filed pursuant to Rule 424(b)(3) |
|
33 | ||
| 08/25/09 | Notice of Effectiveness |
|
1 | ||
| 08/21/09 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 08/18/09 | Current report filing |
|
6 | ||
| 08/13/09 | Registration statement for specified transactions by certain issuers |
|
58 |